David G. Sawutz

1.5k total citations
41 papers, 730 citations indexed

About

David G. Sawutz is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, David G. Sawutz has authored 41 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Genetics and 11 papers in Oncology. Recurrent topics in David G. Sawutz's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers), Chemical Synthesis and Analysis (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). David G. Sawutz is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers), Chemical Synthesis and Analysis (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). David G. Sawutz collaborates with scholars based in United States, Australia and Canada. David G. Sawutz's co-authors include Joseph M. Salvino, Peter R. Seoane, Roland E. Dolle, C J Homcy, Brent Douty, Rhonda Bassel‐Duby, Stephen M. Lanier, Christopher D. Warren, Quang T. Nguyen and Fernand Gobeil and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

David G. Sawutz

40 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David G. Sawutz United States 17 382 331 132 126 113 41 730
Laurie Witucki United States 9 760 2.0× 76 0.2× 140 1.1× 56 0.4× 62 0.5× 12 1.0k
Walter OBERTHÜR Germany 16 553 1.4× 122 0.4× 130 1.0× 113 0.9× 152 1.3× 34 986
Barry R. Cunningham United States 8 409 1.1× 54 0.2× 165 1.3× 138 1.1× 149 1.3× 11 763
Sabine Suire United Kingdom 16 942 2.5× 136 0.4× 160 1.2× 335 2.7× 55 0.5× 21 1.4k
Lars J. Brandén Sweden 14 546 1.4× 125 0.4× 54 0.4× 237 1.9× 25 0.2× 26 911
Hiroshi Onogi Japan 14 886 2.3× 76 0.2× 122 0.9× 71 0.6× 42 0.4× 16 1.2k
C. Lacombe France 17 416 1.1× 184 0.6× 31 0.2× 79 0.6× 54 0.5× 53 796
Nethaji Thiyagarajan United Kingdom 15 494 1.3× 61 0.2× 45 0.3× 64 0.5× 28 0.2× 25 681
Colin J. Traer United Kingdom 9 890 2.3× 67 0.2× 62 0.5× 115 0.9× 104 0.9× 9 1.4k
Brendan J. Classon Australia 19 537 1.4× 39 0.1× 342 2.6× 521 4.1× 66 0.6× 29 1.2k

Countries citing papers authored by David G. Sawutz

Since Specialization
Citations

This map shows the geographic impact of David G. Sawutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Sawutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Sawutz more than expected).

Fields of papers citing papers by David G. Sawutz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Sawutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Sawutz. The network helps show where David G. Sawutz may publish in the future.

Co-authorship network of co-authors of David G. Sawutz

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Sawutz. A scholar is included among the top collaborators of David G. Sawutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Sawutz. David G. Sawutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Narayan, Vikram M., Sharada Mokkapati, Alberto Martini, et al.. (2024). Urinary minimal residual disease detection predicts recurrence in BCG-unresponsive NIMBC and quantifies molecular response to nadofaragene firadenovec.. Journal of Clinical Oncology. 42(4_suppl). 635–635.
2.
Mitra, Anirban P., Sharada Mokkapati, Tanner Miest, et al.. (2022). MP54-05 EVALUATING INTRAVESICAL NADOFARAGENE FIRADENOVEC AND IMMUNE CHECKPOINT BLOCKADE COMBINATION THERAPY IN BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: EVIDENCE FROM A PHASE 3 TRIAL. The Journal of Urology. 207(Supplement 5). 1 indexed citations
3.
Narayan, Vivek, Stephen A. Boorjian, Badrinath R. Konety, et al.. (2021). Subgroup analyses of the phase 3 study of intravesical nadofaragene firadenovec in patients with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC). European Urology. 79. S1026–S1027. 1 indexed citations
4.
Boorjian, Stephen A., Neal D. Shore, Daniel Canter, et al.. (2017). Intravesical rad-IFNα/Syn3 for patients with high-grade, bacillus Calmette-Guérin (BCG) refractory or relapsed non-muscle invasive bladder cancer: A phase II randomized study.. Journal of Clinical Oncology. 35(6_suppl). 279–279. 1 indexed citations
5.
Cablewski, T., et al.. (2011). 2-Phenylimidazo[1,2-b]pyridazine derivatives highly active against Haemonchus contortus. Bioorganic & Medicinal Chemistry Letters. 21(14). 4160–4163. 12 indexed citations
6.
Liepa, Andris J., Adam G. Meyer, David G. Sawutz, et al.. (2007). Parasiticidal 2-alkoxy- and 2-aryloxyiminoalkyl trifluoromethanesulfonanilides. Bioorganic & Medicinal Chemistry Letters. 18(1). 252–255. 7 indexed citations
7.
Saubern, Simon, et al.. (2006). Discovery of (Z)-2-phenyl-3-(1H-pyrrol-2-yl)acrylonitrile derivatives active against Haemonchus contortus and Ctenocephalides felis (cat flea). Bioorganic & Medicinal Chemistry Letters. 17(4). 993–997. 16 indexed citations
9.
Sawutz, David G., Douglas S. Krafte, Joseph J. Oleynek, & Brian Ault. (1995). AMPA (amino-3-hydroxy-5-methylisoxazole-4-propionic acid) Receptors in human brain tissues. Journal of Receptors and Signal Transduction. 15(6). 829–846. 7 indexed citations
10.
Subramanyam, Chakrapani, Brian Ault, David G. Sawutz, et al.. (1995). 6-(4-Pyridinyl)-1H-1,2,3-triazolo[4,5-d]-pyrimidin-4(5H)-one: A Structurally Novel Competitive AMPA Receptor Antagonist. Journal of Medicinal Chemistry. 38(4). 587–589. 3 indexed citations
11.
Sawutz, David G., et al.. (1995). Pharmacology and structure – activity relationships of the nonpeptide bradykinin receptor antagonist WIN 64338. Canadian Journal of Physiology and Pharmacology. 73(7). 805–811. 12 indexed citations
12.
Baine, Yaela, Paul D. Miller, Cheryl A. Hobbs, et al.. (1995). Functional characterization of novel IL-2 transcriptional inhibitors.. The Journal of Immunology. 154(8). 3667–3677. 7 indexed citations
13.
Hoyer, Daniël, et al.. (1995). Ace inhibitors as a template for the design of bradykinin B2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 5(4). 367–370. 11 indexed citations
14.
Sawutz, David G., Joseph M. Salvino, Roland E. Dolle, et al.. (1994). The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist.. Proceedings of the National Academy of Sciences. 91(11). 4693–4697. 73 indexed citations
15.
Sawutz, David G., Joseph M. Salvino, Peter R. Seoane, et al.. (1994). Synthesis, Characterization, and Conformational Analysis of the D/L-Tic7 Stereoisomers of Bradykinin Receptor Antagonist D-Arg0[Hyp3,Thi5,D-Tic7,Oic8]bradykinin. Biochemistry. 33(9). 2373–2379. 19 indexed citations
16.
Dolle, Roland E., Joseph A. Dunn, Mark A. Bobko, et al.. (1994). 5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase. Journal of Medicinal Chemistry. 37(17). 2627–2629. 36 indexed citations
17.
Regoli, D., Fernand Gobeil, Quang T. Nguyen, et al.. (1994). Bradykinin receptor types and B2 subtypes. Life Sciences. 55(10). 735–749. 81 indexed citations
18.
Sawutz, David G., John M. Yanni, Marian Kelley, & Henry R. Wolfe. (1991). Synthesis and molecular characterization of a biotinylated analog of [Lys]bradykinin. Peptides. 12(5). 1019–1024. 2 indexed citations
19.
Sawutz, David G., Laureen Sena, Lawrence E. Cornett, & Robert M. Graham. (1987). Alpha1-adrenergic receptor photoaffinity labeling in intact cells. Biochemical Pharmacology. 36(22). 4027–4032. 2 indexed citations
20.
Sawutz, David G., Diana L. Sylvestre, & C J Homcy. (1985). Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.. The Journal of Immunology. 135(4). 2713–2718. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026